Red Flag Presentations of Immunoglobulin Light Chain Amyloidosis in Patients With Multiple Myeloma - The ASCO Post
Mutations in Specific Structural Regions of Immunoglobulin Light Chains Are Associated with Free Light Chain Levels in Patients with AL Amyloidosis | PLOS ONE
Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease? | JACC: Cardiovascular Imaging
Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis - ScienceDirect
Exploiting endogenous and therapy-induced apoptotic vulnerabilities in immunoglobulin light chain amyloidosis with BH3 mimetics | Nature Communications
AL - Australian Amyloidosis Network
Light Chain Myeloma: Symptoms, Treatment, Outlook, More
Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021 | Blood Cancer Journal
Light-chain amyloidosis: SCT, novel agents and beyond | Bone Marrow Transplantation
Antibody Treatment Holds Promise for Patients with Relapsed or Refractory Light-Chain Amyloidosis – Consult QD
Genetic pathogenesis of immunoglobulin light chain amyloidosis: basic characteristics and clinical applications | Experimental Hematology & Oncology | Full Text
Hemato | Free Full-Text | Light Chain Stabilization: A Therapeutic Approach to Ameliorate AL Amyloidosis
Structure and energetic basis of overrepresented λ light chain in systemic light chain amyloidosis patients - ScienceDirect